InterAACT
Anal cancer is a relatively uncommon disease and there is currently no standard chemotherapy
treatment for patients with inoperable locally recurrent or metastatic disease. The aim of
this phase II study is compare two well known and largely used chemotherapy regimens -
Cisplatin plus 5-fluorouracil vs Carboplatin plus Paclitaxel. The result of this study will
set a standard of care for this disease and provide useful information for future Phase III
trials.
Dec 31,2013
All
18 Years
N/A
18 Years
N/A
80